Answers are grounded in this paper and cite their sources.
Intratumoral heterogeneity drives immunotherapy resistance, hindering clinical efficacy. Functional assays that capture heterogeneous responses to immunotherapies remain limited. Here, we present a 3D live imaging assay using patient-derived ovarian cancer organoids to quantify natural killer (NK) cell-induced apoptosis across hundreds of individual organoids. Our assay reveals inter- and intratumor response heterogeneity and detects rare populations unresponsive to NK cytotoxicity, enabling the study of subclonal immune responses and underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Mercadante et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: